Phivea® platform

The Phivea® Platform opens the door to future care and treatment of genetic disorders Share it: See also 27 Sep 2022 gMendel® moves into an investment agreement with Polish biotech company genXone for further cooperation in diagnosis of genetic disorders. 29 Aug 2022...